Medivir AB (publ)

Medivir AB (publ)verified

MVRBF

Price:

$0.82

Market Cap:

$402.33M

Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics...[Read more]

Industry

Biotechnology

IPO Date

2010-06-22

Stock Exchange

OTC

Ticker

MVRBF

The Enterprise Value as of November 2025 (TTM) for Medivir AB (publ) (MVRBF) is 411.40M

According to Medivir AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 411.40M. This represents a change of -9.28% compared to the average of 453.46M of the last 4 quarters.

Medivir AB (publ) (MVRBF) Historical Enterprise Value (quarterly & annually)

How has MVRBF Enterprise Value performed in the past?

The mean historical Enterprise Value of Medivir AB (publ) over the last ten years is 1.57B. The current 411.40M Enterprise Value has changed 2.52% with respect to the historical average. Over the past ten years (40 quarters), MVRBF's Enterprise Value was at its highest in in the June 2014 quarter at 5.20B. The Enterprise Value was at its lowest in in the December 2020 quarter at 204.04M.

Quarterly (TTM)
Annual

Average

1.57B

Median

956.33M

Minimum

204.04M

Maximum

3.69B

Medivir AB (publ) (MVRBF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Medivir AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 188.42%

Maximum Annual Enterprise Value = 3.69B

Minimum Annual Increase = -59.18%

Minimum Annual Enterprise Value = 204.04M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022560.85M-4.70%
2021588.49M188.42%
2020204.04M-45.79%
2019376.37M-44.59%
2018679.29M-44.92%
20171.23B-59.18%
20163.02B43.91%
20152.10B-43.17%
20143.69B14.54%
20133.23B18.42%

Medivir AB (publ) (MVRBF) Average Enterprise Value

How has MVRBF Enterprise Value performed in the past?

The current Enterprise Value of Medivir AB (publ) (MVRBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

451.13M

5-year avg

481.81M

10-year avg

1.57B

Medivir AB (publ) (MVRBF) Enterprise Value vs. Peers

How is MVRBF’s Enterprise Value compared to its peers?

Medivir AB (publ)’s Enterprise Value is less than Abliva AB (publ) (683.00M), greater than Relief Therapeutics Holding AG (24.49M), less than Oncopeptides AB (publ) (1.14B), greater than Biostage, Inc. (57.29M), greater than Small Pharma Inc. (34.17M), greater than Mindset Pharma Inc. (66.42M), greater than Alpha Cognition Inc. (34.21M), greater than Herantis Pharma Oyj (50.66M), greater than Karolinska Development AB (publ) (49.34M), greater than IntelGenx Technologies Corp. (42.91M),

Build a custom stock screener for Medivir AB (publ) (MVRBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medivir AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medivir AB (publ) (MVRBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medivir AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Medivir AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Medivir AB (publ) (MVRBF)?

What is the 3-year average Enterprise Value for Medivir AB (publ) (MVRBF)?

What is the 5-year average Enterprise Value for Medivir AB (publ) (MVRBF)?

How does the current Enterprise Value for Medivir AB (publ) (MVRBF) compare to its historical average?